Department of Otolaryngology, Ajou University School of Medicine, Suwon, Korea.
Clin Exp Otorhinolaryngol. 2013 Sep;6(3):127-34. doi: 10.3342/ceo.2013.6.3.127. Epub 2013 Sep 4.
Mastoid obliteration is used to obliterate the mastoid cavity following a mastoidectomy or to prevent the formation of a retraction pocket. This study evaluated the effectiveness of β-tricalcium phosphate and polyphosphate (β-TPP) for mastoid obliteration in middle ear surgeries in prospective human and animal studies.
Twenty patients with chronic otitis media underwent mastoid obliteration using β-TPP after a intact canal wall mastoidectomy or simple mastoidectomy. The clinical data were prospectively evaluated including: the diagnosis, temporal bone computed tomography (TBCT), otoscopic findings, pure tone audiogram, and complications. In the animal experiment, β-TPP was applied into the right bulla in five rats, and the opposite bulla was used as the control in the non-obliterated state. The skulls of five other rats were drilled out and the holes were obliterated with β-TPP. TBCT were obtained at 3, 6, and 9 months after the obliteration and histologic analysis was done at 3 and 9 months after surgery.
In the human study, fourteen TBCTs were obtained at 12 months after the surgery. All demonstrated no bone resorption in the obliterated mastoids. Among the 15 cases displaying retracted tympanic membranes preoperatively, 11 showed no retraction, 2 showed retraction postoperatively, 1 was lost to follow-up and 1 was a case of postoperative wound infection. Among 20 cases, one case developed a postoperative infection that necessitated a second operation. Sixteen underwent ossiculoplasty; hearing improvements were obtained in 15 cases and 1 case showed decreased hearing. In the animal study, new bone formation without significant bone resorption in the radiologic and histologic findings were noted in both the skull and bulla groups.
Although β-TPP is a foreign material having the possibility of infection, mastoid obliteration with it can be a treatment option in middle ear surgeries to prevent retraction pockets or the recurrence of diseases.
乳突填塞术用于填塞乳突切除术后的乳突腔或防止回缩袋的形成。本研究评估了β-磷酸三钙和多磷酸盐(β-TPP)在中耳手术中进行乳突填塞的有效性,包括前瞻性人体和动物研究。
20 例慢性中耳炎患者在完整的鼓室盖型乳突切除术或单纯乳突切除术之后使用β-TPP 进行乳突填塞。前瞻性评估了临床资料,包括:诊断、颞骨计算机断层扫描(TBCT)、耳镜检查结果、纯音听阈测试和并发症。在动物实验中,将β-TPP 应用于 5 只大鼠的右侧鼓室,而对侧鼓室作为非填塞状态的对照。另外 5 只大鼠的颅骨被钻开,并用β-TPP 填塞钻孔。在填塞后 3、6 和 9 个月获得 TBCT,并在术后 3 和 9 个月进行组织学分析。
在人体研究中,14 例患者在手术后 12 个月进行了 TBCT 检查。所有患者的填塞乳突均未见骨质吸收。在术前鼓膜回缩的 15 例患者中,11 例无回缩,2 例术后有回缩,1 例失访,1 例为术后伤口感染。20 例患者中,1 例发生术后感染,需要再次手术。16 例行听骨链成形术;15 例听力改善,1 例听力下降。在动物研究中,颅骨和鼓室组的影像学和组织学检查均显示有新骨形成,无明显骨质吸收。
尽管β-TPP 是一种具有感染可能性的异物,但在中耳手术中进行乳突填塞可以作为预防回缩袋或疾病复发的治疗选择。